Patricio Lacalle Joins as Chief Executive Officer

RNS Announcement

2 April 2015

Immunodiagnostic Systems Holdings plc

Patricio Lacalle Joins as Chief Executive Officer

Immunodiagnostic Systems Holdings plc ("IDS" or the "Company"), a leading producer of manual and automated specialist diagnostic testing kits and instrumentation for the clinical and research markets quoted on AIM, announces that Patricio Lacalle has officially taken up his position as Chief Executive Officer. In addition, Burkhard Wittek, Executive Chairman, will revert to being Non-Executive Chairman with immediate effect.

The Company can confirm that it will provide a post close trading update on Tuesday 21st April 2015 and Preliminary Results will be announced on Tuesday 23rd June 2015.